Infectious Disease Research Institute

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Site of IDRI's facility in the Eastlake neighborhood of Seattle

The Infectious Disease Research Institute (IDRI) is a non-profit organization based in Seattle, in the United States, and which conducts global health research on infectious diseases.


IDRI was founded in 1993.[1]

Malaria vaccine[edit]

IDRI is collaborating with the United States Agency for International Development to develop a malaria vaccine with the Walter Reed Army Institute of Research using Walter Reed's CelTOS malaria antigen in conjunction with IDRI's GLA-SE adjuvant.[2]

Visceral leishmaniasis vaccine[edit]

On February 2012, IDRI launched the world’s first clinical trial of the visceral leishmaniasis vaccine. The vaccine is a recombinant form of two fused Leishmania parasite proteins with an adjuvant. Two phase 1 clinical trials with healthy volunteers are to be conducted. The first one takes place in Washington and is followed by a trial in India. The trials are funded by the Bill & Melinda Gates Foundation.[3]


  1. ^
  2. ^ Erica Teichert (18 August 2011). "USAID, IDRI form malaria vax collaboration". Retrieved 12 September 2011. 
  3. ^ Elvidge, Suzanne (February 23, 2012). "World's first kala azar vaccine enters the clinic". Retrieved March 1, 2012. 

External links[edit]

Official website

Coordinates: 47°38′3.1″N 122°19′28.7″W / 47.634194°N 122.324639°W / 47.634194; -122.324639